Skip to main content
Log in

One-dose and two-dose US varicella vax strategies worth it?

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Zhou F, Ortega-Sanchez IR, Guris D, Shefer A, Lieu T, Seward JF.An economic analysis of the universal varicella vaccination program in the United States. Journal of Infectious Diseases 197 (Suppl. 2): 156-164, 1 Mar 2008

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

One-dose and two-dose US varicella vax strategies worth it?. Pharmacoecon. Outcomes News 548, 4 (2008). https://doi.org/10.2165/00151234-200805480-00009

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200805480-00009

Keywords

Navigation